Sham IVT

OTHER2 trials

Sponsors

Bayer, EyePoint Pharmaceuticals, Inc.

Conditions

Macular DegenerationNonproliferative Diabetic Retinopathy

Phase 2

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

TerminatedNCT02222207

BayerMacular Degeneration

Start: 2014-10-31End: 2015-06-30Updated: 2016-09-08

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

CompletedNCT05383209

EyePoint Pharmaceuticals, Inc.Nonproliferative Diabetic Retinopathy

Start: 2022-09-28End: 2024-05-06Updated: 2025-08-15